ICMR is enabling Emcure and Biological E to commercialize three homegrown technologies for cervical disease and infectious illnesses.
ICMR Transfers Cancer and Vaccine Technologies to Indian Pharma
ICMR is enabling Emcure and Biological E to commercialize three homegrown technologies for cervical disease and infectious illnesses.